Overview
BenchSci is an AI platform designed specifically for biomedical research and the world's first neuro-symbolic AI platform. By introducing the concept of AI coding into scientific research, it equips each scientist with an intelligent agent team composed of PhD-level experts, thereby shortening the cycle from hypothesis generation to experimental design from years to days, significantly accelerating the drug discovery process. The platform integrates data, models, software packages, workflows, lab loops, and scientific reasoning to build a unified environment dedicated to preclinical research and development.
Key Features
- Intelligent Reasoning Engine: The EMET agent workspace can understand complex research questions posed in natural language. Through an orchestration layer, it automatically decomposes the problem, identifies and invokes appropriate domain-specific skills, and performs intelligent reasoning across dozens of trusted scientific databases and over 38 million scientific publications (including 16 million closed-access papers obtained exclusively through partnerships and licenses), rather than simple searching.
- Traceable and Actionable Results: The platform outputs not summaries, but traceable, explainable, and immediately actionable insights covering the entire preclinical R&D process, including hypothesis generation, target identification, experimental design, and lead optimization.
- Scientist-Led Control: EMET positions each researcher as the commander of a PhD-level intelligent agent team, rather than a passive recipient of AI output, ensuring scientists maintain a dominant role throughout the research process.
- Extensive Literature and Data Coverage: The platform accesses 38M+ scientific publications and has exclusive access to 16M closed-access papers, combined with dedicated databases, providing literature mining capabilities far beyond public resources.
- Experimental Reagent and Antibody Search: As one of the label features, the platform supports efficient searching of experimental reagents and antibodies, helping researchers quickly locate needed materials.
- Accelerated Drug Discovery Process: Through automated reasoning and intelligent chaining, it shortens the process from hypothesis to experimental design, which originally took years, to days, significantly improving R&D efficiency.
Use Cases
- Hypothesis generation and validation in drug discovery
- Target identification and lead optimization
- Literature mining and reagent search in experimental design
- Acceleration and optimization of the entire preclinical R&D process
Pros
- Shortens the R&D cycle from years to days, significantly improving efficiency
- Based on neuro-symbolic AI reasoning rather than simple searching, yielding more accurate results
- Scientists maintain full control over the research process, enhancing credibility
- Covers massive amounts of public and closed-access literature, rich in data resources
- Offers a free trial, lowering the barrier to entry
Pricing
Adopts a freemium model; users can try the EMET agent workspace for free, with a dedicated registration channel for academic users.
Summary
BenchSci is suitable for research teams and biotechnology companies engaged in drug discovery and preclinical research, especially those needing to quickly extract actionable insights from vast amounts of literature and accelerate experimental design. Its core advantage lies in achieving intelligent reasoning through neuro-symbolic AI, rather than traditional search, while giving scientists full control over AI output, significantly enhancing R&D efficiency.